Company / PP&E (Net)
Black Diamond Therapeutics, Inc. PP&E (Net) History
FY2019-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$385.0K
FY2020
5-year range
$164.0K / $385.0K
FY2019-FY2020
Trend
+134.8%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$385,000 in FY2020.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, pp&e (net) increased 134.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.60 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2020 | $385.0K | +134.8% |
| FY2019 | $164.0K | - |
As of FY2020 · SEC Form 10-K · Last checked Jun 21, 2026